In cervical cancer, it has been shown that CD147 expression was higher in squamous and adenocarcinoma tissue than in their non-neoplastic counterparts, and both MCT1 and MCT4 were more frequently expressed in CD147 positive cases (90, 95). Here, SLC16A3 is linked to cervical carcinoma.